Would You Like to Buy a Mickey Mantle Baseball Card?
The bad news is they range from $625,000, to as high as the recent record sales price, which was $12.8 million.
The good news, is via Tokenization experts like GoPaid.com, which is a wholly owned division of Vystar Corp (VYST), you may soon be able to buy part of the card (real ownership) as well as other extremely valuable collectables, for as little as $50.
This will open the high-end collectable market, for the first time, to millions of investors. This includes high end art like Calude Monet’s “Haystack” which recently sold for $110.7 million (even the .7 miilion is too expensive).
Let’s dig into the Monet transaction to better understand the enourmous potential and market, for collectables and artwork that GoPaid is addressing. It’s a lot easier to understand than you might imagine, apart from the blockchain technology required to pull it off. That technology has already been established. It just has to be integrated – greatly reducing the risk of the GoPaid.com project, fom many angles.
The seller was a private collector who had originally purchased the painting in 1986 for $2.53 million – a jaw-dropping amount of money at the time. The buyer’s identity was not publicly disclosed, which is typical for high-profile art auctions.
Let’s assume the owner converted his ownership into tokens in 1986. Let’s say after getting authenticated, he decided to price the tokens, equal to what he paid, and thus issue 1 million tokens, similar to an IPO. That would mean the issue price would be $2.53.
1 miilion tokens x $2.53 = the $2.53 million purchase price.
If we asked you to buy the painting for $2.5 million back then, like most, you’d probably pass. Preferring to invest that kind of money into something that provides a yield, as artwork does not pay a dividend!
But what if you wanted to invest a lower amout? Like $25,000 – to own a piece of a Monet? We know 100’s if not thousands of investors who would jump on that. Some would invest that much, just for the brgging rights.
So you buy 10,000 tokens at $2.53 or $25,300. Then with the passage of time, no dividends, no news, no earnings reports, the Monet slowly increases in value to $110.7 million, or $110.70 a token.
New value of the 10,000 tokens purchased for $25,000 = $1,107,000.
It’s really that easy to understand the opportunity that Vystar and GoPaid.com have ahead of them. Like they used to say during the dotcom boom, “Things could work out, even if things don’t work out. With markets this large, they could accident them into success.”
Finally, in addition to blasting the market open to million of investors, instead of a handful, we beleive this will crack open the availabilty of ultra high-price works, that may have been collecting dust for decades.
No one wants to sell the ‘baby.’ But what if the owner of the Monet wanted to sell a 10% stake and pocket $11 million and buy a little Chalet in the South of France?
He doesn’t want to sell the whole painting. Just a little piece.
Now he can do that, and now the owners of other Master Works can too. It’s truly world changing.
Subscribe for updates on Vystar (VYST).
Additional Reading
Mickey Mantle: Everything you need to know about one of the hobby’s most iconic cards.
Mickey Mantle: 1952 Topps Mickey Mantle baseball card sells for $2.88 million
From Mondrian to Man Ray, Here Are the Best-Sellers at Auction So Far This Year
RECENT HIGH PRICED ART SALES.
Old Masters
Impressionist and Modern
Postwar
Contemporary
Ultra-Contemporary
Disclaimer.
About Vystar Corporation:
Based in Worcester, Mass., Vystar® Corp. (OTCQB: VYST) is the owner of RxAir® UV light air purification products that destroy harmful airborne viruses and pathogens, Vytex® Natural Rubber Latex (NRL), and Fluid Energy Solutions. Vytex is a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex for a stronger, more durable, yet environmentally safe, “green” and fully biodegradable product that can be used in a broad range of consumer and medical products. For more information, visit www.vystarcorp.com.
Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are “Forward-Looking Statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as “believes,” “anticipates,” “intends,” “plans,” “expects,” and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, product development and delivery, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements. Please see report for disclosure and disclaimer details.
